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Provisional Tic Disorder is not so
transient
Soyoung Kim 1, Deanna J. Greene1,2, Emily C. Bihun1, Jonathan M. Koller 1,
Jacqueline M. Hampton3, Haley Acevedo1, Angela M. Reiersen1, Bradley L. Schlaggar4,5,6 &
Kevin J. Black 1,2,3,7
Motor and vocal tics are common in childhood. The received wisdom among clinicians is that for
most children the tics are temporary, disappearing within a few months. However, that common
clinical teaching is based largely on biased and incomplete data. The present study was designed to
prospectively assess outcome of children with what the current nomenclature calls Provisional Tic
Disorder. We identified 43 children with recent onset tics (mean 3.3 months since tic onset) and reexamined 39 of them on the 12-month anniversary of their first tic. Tic symptoms improved on a group
level at the 12-month follow-up, and only two children had more than minimal impairment due to tics.
Remarkably, however, tics were present in all children at follow-up, although in several cases tics were
apparent only when the child was observed remotely by video. Our results suggest that remission of
Provisional Tic Disorder is the exception rather than the rule. We also identified several clinical features
present at the first examination that predict one-year outcome; these include baseline tic severity,
subsyndromal autism spectrum symptoms, and the presence of an anxiety disorder.
Tics are sudden, rapid, recurrent, nonrhythmic movements or vocalizations such as eye blinking or throat clearing1,2. Tics are common in childhood, with a generally accepted prevalence rate of 20%3–6, though we have argued
that the true prevalence may be much higher7. On the other hand, only about 3% of all children have tics for the
year that is required to diagnose Tourette syndrome or a chronic tic disorder (hereafter “TS”)3,8. When tics have
not yet lasted a year since onset, Provisional Tic Disorder (PTD) is diagnosed2. Since every child with chronic tics
could have been diagnosed with PTD during the first year after tics started, some children with PTD must experience marked improvement or remission of tics within the first year, while others go on to a diagnosis of TS. Thus,
TS can be conceptualized as a two-step process: tics appear, and then they fail to remit. The epidemiological data
summarized above would suggest that the second step is the more unusual, with PTD remitting the large majority
of the time. However, little existing research on tics has focused on PTD.
Nevertheless, studying the PTD population is important, both in its own right and for the implications for TS.
Children with recent-onset tics and their parents want to know prognosis. At present, there is almost no information to determine which children will go on to need long-term treatment. Studying this population also offers
the tantalizing possibility of secondary prevention of tic disorders (i.e., preventing progression to chronicity).
Previous cross-sectional studies that find an association between TS and a particular biological marker usually
are unable to determine whether the association is causal, and if so whether the marker is a consequence or cause
of the disease9. By contrast, a prospective study, starting before tics become chronic, may answer these questions.
For example, abnormalities in TS that are also present in PTD are unlikely to reflect chronicity or adaptation.
Additionally, the causes of tic appearance and of tic disappearance may differ. Unfortunately, few studies have targeted patients during the first year of ticcing and their findings are generally retrospective, sparse, and contradicting10–12. While limited prospective data suggest that only a third of children with PTD show complete remission
of tics over the next 5–10 years7, the epidemiology reviewed above suggests otherwise, and experts have opined
that PTD usually remits within a few months2,10,13–21.
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Here we present the largest face-to-face, prospective study of clinical outcomes in PTD. This project includes
structural and functional MRI, a standardized tic suppression protocol, and various neuropsychological tests
(www.NewTics.org). Here we report the clinical outcomes of the first 43 participants at 12 months after the first
tic (i.e., when TS can first be diagnosed). We also explored baseline clinical predictors (collected at the first visit)
of tic outcome at 12 months. The study continues, but the protocol changed after these 43 were enrolled; thus, this
cohort is well suited for investigation of the clinical data.

Results

Baseline characteristics.

Table 1 summarizes the clinical features of participants at baseline and at the
12-month follow-up visit. Their baseline visit occurred on average 3 months after their first tic, at a mean age of
8.1 years (all but 4 were 5.0–10.9 years old). Past week tic severity at the baseline visit was modest on average,
with a mean YGTSS score (total tic score [TTS] + impairment score) of 24.98. The TTS ranged from 7 to 30; 5
participants showed minimal tic severity (TTS ≤ 10), 29 showed mild tic severity (score 11–20), and 9 showed
moderate to severe tic severity (score > 20). The impairment score ranged from 0 to 30; 33 participants reported
minimal impairment (score 0–10), 7 reported mild impairment (11–20), and 3 reported moderate impairment
(score 21–30). Only 7 out of 35 participants were judged (by KJB) to ever have had impairment in a life role or
marked distress associated with tics (not recorded for 8 participants). As expected, participants had experienced
fewer classic TS symptoms during the short course of their illness than a typical TS population (mean DCI score
at baseline was 31.84 ± 13.95; though the range was broad: 14–80). Nevertheless, the symptoms were generally
concerning to parents; the parents of 12 out of 15 participants answered “yes” when asked at screening if they
would be taking their child to a doctor because of the tics (this question was added midway through the study).
Nearly all participants met criteria for another psychiatric diagnosis. Specifically, K–SADS revealed one or more
diagnosis other than tic disorders in 35 participants: 18 participants met criteria for ADHD, 6 participants had
OCD, and 20 participants had an anxiety disorder (other than OCD).

Outcome. Four children did not return for their 12-month visit. Clinical features of the group at baseline did
not significantly change with the removal of these children, except that all four had ADHD (Table 1). Outcomes
are reported for the remaining 39 children. Overall, tic severity improved over time. The YGTSS TTS declined by
an average of 18% at the 12-month visit compared to the baseline visit (p = 0.007; Table 1). The number of participants with a current complex tic decreased from 27 to 21. All but two participants reported minimal impairment
(YGTSS impairment ≤10) at the 12-month visit. Few parents (3 of 29 asked) were planning to seek further clinical
care at this time for their child’s tics. Only six met DSM-IV criteria for Tourette’s Disorder (which require impairment in a life role or marked distress). In fact, at the 12-month visit, several (at least 9 of 28) had no tics observed
during extensive clinical history review or neurological examination.
Remarkably, however, at follow-up all children had tics within the past week. Three children and their parents
(out of 29) said they had not noticed any tic within the past week (not explicitly recorded for 10 early subjects).
However, these three children showed tics when alone (observed remotely by video). Out of 39 participants, all
but one child showed tics when observed alone; the child with no tics on video had parent-reported tics within
the past week and was observed to tic on a later encounter. Thus, all but four children met DSM-IV-TR criteria
(which do not require impairment or marked distress) for Tourette’s Disorder and three of those four met criteria
for Chronic Motor Tic Disorder (See Table 2). The remaining child had reportedly experienced an intervening
asymptomatic period of a few months, for a DSM-IV-TR diagnosis of a second episode of Transient Tic Disorder.
Every child met DSM-5 criteria for Tourette’s Disorder or Chronic Motor Tic Disorder (as DSM-5 does not
exclude brief remissions). Even if all 4 of the participants lost to follow-up remitted completely, at least 90%
(39/43) of the total sample still showed tics at the one-year anniversary of tic onset. With 95% confidence, these
numbers indicate that tics persist to the one-year mark in at least 78% of children with PTD [95% confidence
interval (CI) for the proportion 39/43 = 0.784, 0.96322]. This percentage is much higher than previously accepted
estimates.
DCI scores, which measure typical features of TS, increased from the baseline to the 12-month visit. The DCI
score cannot decrease, as it represents a cumulative account of features ever observed, but this change indicates
that additional clinical features continued to accrue over the 6- to 12-month interval between visits. The mean
DCI score at the 12-month visit was 41.28, representing a fairly typical history for early TS, but the range was
broad (13–74). Pearson’s correlation analysis revealed a significant correlation between TTS and DCI scores at
both the baseline visit, r = 0.507, p < 0.001, and the 12-month visit, r = 0.676, p < 0.001. The change in these two
variables between visits, ΔTTS and ΔDCI, also correlated, r = 0.373, p = 0.019, such that the participants who
showed a smaller reduction (or a greater increase) in TTS at the 12-month visit also showed a greater increase in
DCI at the 12-month visit.
PUTS scores, reflecting awareness of premonitory symptoms, also increased by the 12-month visit. There
was no significant correlation between TTS and PUTS either at the baseline visit (rs (35) = −0.07, p = 0.68) or
the 12-month follow-up visit (rs (34) = 0.26, p = 0.13) or between ΔTTS and ΔPUTS (r(30) = −0.02, p = 0.90).
Previous studies have noted that the PUTS can be less reliable in children under 10 years old, as their ability to
report premonitory urges can be limited23,24. Six participants at the baseline visit and three participants at the
12-month visit were not able to complete the PUTS due to the difficulty in reporting these internal phenomena.
Prognosis. We tested if clinical features at baseline could predict clinically relevant tic outcome in terms of
the 12-month YGTSS TTS. We hypothesized that baseline TTS and PUTS scores would be associated with tic outcome at the 12-month visit. The 12-month TTS was strongly associated with baseline TTS, r = 0.456, p = 0.004,
so additional analyses controlled for baseline TTS using partial correlations and ANCOVAs. PUTS was not associated with tic outcome, rpartial = 0.063, p = 0.727 (Spearman). In addition, we examined the candidate predictor
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Baseline All participants Baseline 12-month completed 12-month Follow-up
n = 43
n = 39
n = 39
Descriptor

mean ± sd or count

mean ± sd or count

Age

8.13 ± 2.43

7.97 ± 2.28

Sex

30 M/13F

26 M/13F

Handedness

39 R/4L

35 R/4L

mean ± sd or count

t

p

Non-white

4

3

Barratt SES

50.81 ± 10.76

50.99 ± 10.96

K-BIT IQ

109.23 ± 12.83

109.28 ± 12.5

Days since tic onset

99.74 ± 41.91

98.38 ± 43.39

372.79 ± 15.43

YGTSS Total

24.98 ± 12.57

24.85 ± 12.8

18.13 ± 11.4

2.86

0.01

- TTS (total tic)

17.23 ± 6.15

17.21 ± 6.13

14.15 ± 6.63

2.86

0.01

- Motor

10.95 ± 3.71

10.87 ± 3.83

9.15 ± 4.19

2.8

0.01

- Phonic

6.28 ± 4.58

6.33 ± 4.55

5 ± 3.54

1.76

0.09

- Impairment

7.74 ± 7.81

7.64 ± 8.09

3.85 ± 5.79

2.42

0.02

- Minimal Impairment

33

30

37

- Complex Tics (Present)

30

27

21

Vocal Tics (ever)

35

32

35

PUTS*

13.03 ± 4.57

12.65 ± 3.84

15.67 ± 6.11

−2.7

0.01

DCI

31.84 ± 13.95

30.87 ± 13.7

41.28 ± 16.31

−7.2

0

1st degree relative with tics

16

15

- Parent with tics
Non-tic K-SADS Diagnosis

10

9

35

31

ADHD Diagnosis

18

14

OCD Diagnosis

6

5

Anxiety Disorder

20

20

Medication

5

3

PedsQL - Total

84.37 ± 10.34

83.84 ± 10.63

85.34 ± 11.53

−0.9

0.39

- Physical Functioniing

90.62 ± 11.81

89.98 ± 12.17

90.87 ± 13.13

−0.4

0.7

- Emotional Functioning

79.3 ± 18.08

77.69 ± 18.2

80.9 ± 18.24

−1.4

0.17

- Social Functioning

86.63 ± 16.79

85.51 ± 17.2

90.9 ± 10.06

−2.3

0.03

- School Functioning

80.93 ± 16.08

82.18 ± 15.68

78.72 ± 17.69

1.31

0.2

49.79 ± 8.55

50.08 ± 8.62

- Awareness T scores

53.19 ± 9.08

53.38 ± 9.07

- Cognition T scores

49.7 ± 8.24

49.92 ± 8.33

- Communication T scores

48.6 ± 8.52

48.87 ± 8.61

- Motivation T scores

50.23 ± 9.36

50.41 ± 9.57

- Mannerisms T scores

50.56 ± 10.25

50.95 ± 10.45

165.63 ± 14.2

166.21 ± 14.6

164.95 ± 18.44

0.42

0.68

- Anxious/Depressed

54.56 ± 6.25

55 ± 6.41

54.89 ± 7.59

0.03

0.97

- Attention Problems

56.02 ± 6.14

55.92 ± 6.25

55.73 ± 8

−0.2

0.86

- Aggressive Behavior

55.05 ± 6.16

55.28 ± 6.38

54.32 ± 5.83

0.97

0.34

SRS total T scores

CBCL – DESR**

Table 1. Characteristics of study participants at the baseline and 12-month follow-up visit. Continuous data
are summarized as mean ± SD. Paired t tests were conducted to compare the baseline and 12-month follow-up
visits where applicable. “Non-white” includes 1 participant who did not report race. “YGTSS – Minimal
Impairment” indicates the number of participants who scored 10 or below on the YGTSS Impairment scale.
“Anxiety Disorder” includes panic disorder, separation anxiety disorder, social anxiety disorder, agoraphobia,
specific phobia, generalized anxiety disorder (DSM-IV), and avoidant disorder of childhood (DSM-III-R). *37
participants completed the PUTS at baseline, 34 of whom completed the 12-month follow-up visit; 36 children
completed the PUTS at the 12-month follow-up visit. **All participants completed the CBCL at baseline, but 37
completed the CBCL at the 12-month follow-up visit.
variables listed in Tables 3 and 4 based on previous literature (Fig. 1). These additional analyses can be considered
exploratory, so the uncorrected p values should be considered with caution.
One participant was removed from the analysis of DCI total score as an outlier. For the remaining participants, DCI total score trended toward significantly predicting 12-month TTS, controlling for baseline TTS,
rpartial = 0.320, p = 0.054 (Spearman), such that participants with higher DCI total scores at the baseline visit had
higher TTS at the 12-month visit. The estimated Bayes factor BF10 was 1.40, indicating weak evidence in favor
of the model with DCI total score and baseline TTS over the null model with baseline TTS alone. Partial correlation also revealed a marginally significant relationship between SRS (total) T score at baseline and 12-month
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Tic Disorder

Comorbidity

Doctor?

Baseline

12-month Follow-up

Study ID

DSM-5

DSM-IV

DSM-IV-TR DSM-5

Baseline

12-month follow-up

Baseline

12-month
follow-up

NT701

PTD

ND

TS

TS

ADHD

ADHD

—

No

NT702

PTD

ND

TS

TS

OCD

OCD

—

—

NT703

PTD

ND

TS

TS

ADHD

ADHD

—

No

NT704

PTD

N/A

N/A

N/A

ADHD, OCD

N/A

—

—

NT705

CMTD

N/A

N/A

N/A

ADHD

N/A

—

—

NT707

PTD

TS

TS

TS

ADHD

ADHD

—

—

NT709

PTD

N/A

N/A

N/A

ADHD

N/A

—

—

NT710

PTD

ND

TS

TS

ADHD

ADHD, OCD

—

—

NT712

PTD

ND

TS

TS

ND

ND

—

—

NT713

PTD

ND

TS

TS

ADHD

ADHD

—

—

NT714

TS

ND

TS

TS

ND

ND

—

—

NT715

PTD

ND

TTD*

CMTD

OCD

ADHD

—

—

NT716

PTD

ND

TS

TS

ADHD, OCD

ND

—

—

NT718

PTD

ND

TS

TS

ND

ND

—

—

NT719

PTD

TS

TS

TS

ND

ADHD

—

—

NT720

PTD

TS

TS

TS

OCD

ADHD, OCD

—

—

NT722

PTD

ND

CMTD

CMTD

ADHD

ADHD

—

No

NT724

PTD

ND

TS

TS

ND

ND

—

No

NT726

PTD

TS

TS

TS

ADHD

ADHD, OCD

—

Yes

NT728

PTD

ND

TS

TS

ADHD, OCD

ADHD

—

No

NT729

PTD

ND

TS

TS

ND

ND

—

No

NT730

PTD

ND

TS

TS

ND

ND

—

No

NT731

PTD

ND

TS

TS

N

ND

—

No

NT732

PTD

ND

TS

TS

ND

OCD

—

No

NT733

PTD

ND

TS

TS

ND

ND

Yes

Yes

NT734

TS

ND

TS

TS

ND

ADHD

—

No

NT735

PTD

ND

TS

TS

ND

ND

Yes

No

NT736

PTD

TS

TS

TS

ADHD

ADHD, OCD

Yes

No

NT738

PTD

TS

TS

TS

ND

ND

Yes

No

NT801

PTD

ND

TTD*

TS

ND

ND

Yes

No

NT805

PTD

ND

TS

TS

ADHD

ND

No

No

NT806

PTD

ND

TS

TS

ND

ND

—

No

NT807

PTD

ND

TS

TS

ND

ND

Yes

No

NT808

PTD

ND

CMTD

CMTD

ND

ND

No

No

NT809

PTD

ND

TS

TS

ADHD

ADHD

Yes

No

NT810

PTD

ND

TS

TS

ND

ND

Yes

No

NT811

PTD

ND

TS

TS

ND

OCD

—

No

NT812

PTD

ND

TS

TS

ND

OCD

Yes

No

NT813

PTD

N/A

N/A

N/A

ADHD

N/A

Yes

Yes

NT814

PTD

ND

TS

TS

ADHD

ADHD

Yes

No

NT815

PTD

ND

TS

TS

ND

ND

Yes

Yes

NT816

PTD

ND

TS

TS

ND

ND

—

No

NT817

PTD

ND

TS

TS

ADHD

ADHD

No

No

Table 2. Participant diagnoses. In the DSM-IV column, ND indicates No Diagnosis; alternatively one might
diagnose Tic Disorder Not Otherwise Specified (for which the criteria do not specify impairment or marked
distress). TTD* in the DSM-IV-TR column indicates a second (or later) episode of TTD; tics were present
at the 12-month follow-up visit in each of these cases. TS is used for Tourette’s Disorder. “Doctor?”: Parent
answered “yes” to the question, [excluding the visit for this research study], “would you be taking your child to
the doctor now (or in the near future) because of his/her tics?”. Dash (−) indicates missing data. N/A indicates
a participant who did not complete the 12-month follow-up visit. CMTD: chronic motor tic disorder; PTD:
provisional tic disorder; TS: Tourette syndrome; TTD: transient tic disorder. “ADHD” includes ADHD Not
Otherwise Specified as well as any subtype of ADHD.

TTS, controlling for baseline TTS, rpartial = 0.312, p = 0.056 (Spearman). The estimated Bayes factor BF10 was
27.48, indicating strong evidence in favor of adding SRS (total) T score to the null model with baseline TTS
alone. Correlation analyses were also conducted separately for the five SRS Treatment Subscale T scores (Social
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Pearson Correlation

Spearman Correlation

Predictor

n

partial r

partial r

PUTS total

34

0.094

DCI total
ADHD Rating Scale

38
39

0.327
0.103

p value

p value

0.602

0.063†

0.727†

0.048

0.320

†

0.054†

0.538

0.089

†

0.594†

†

0.246†
0.248†

CY-BOCS

38

0.12

0.479

0.195

Age at tic onset

39

0.264

0.11

0.192†

Interval_between_visits

39

−0.202

0.225

−0.193

0.247

K-Bit IQ

39

−0.13

0.438

−0.05

0.766

SES

39

−0.228

0.169

−0.174†

0.297†

SRS total T scores

39

0.482

0.002

0.312†

0.056†

- SRS awareness T scores

39

0.111

0.506

0.079

0.637

- SRS cognition T scores

39

0.232

0.16

0.251

0.128

- SRS communication T scores

39

0.479

0.002

0.381†

0.018†

0.001

0.414

†

0.010†

0.000

0.389

†

0.016†

†

0.011†
0.014†

- SRS motivation T scores
- SRS mannerisms T scores

39
39

0.498
0.542

39

0.362

0.026

0.406

- CBCL - Anxious/Depressed

38

0.431

0.008

0.400†

- CBCL - Attention Problems

39

0.328

0.045

0.244†

0.139†

- CBCL - Aggressive Behavior

39

0.242

0.143

0.268†

0.103†

CBCL - A-A-A (DESR)

Table 3. Partial correlations between continuous predictor variables and 12-month tic severity (YGTSS total
tic score) controlling for baseline tic severity. Dagger (†) in the Spearman correlation columns indicates that
the data were not normally distributed (tested by Shapiro-Wilk test). CBCL = Child Behavior CheckList; CYBOCS = Child Yale-Brown Obsessive Compulsive Scale; DCI = Diagnostic Confidence Index; DESR = deficient
emotional self-regulation; PUTS = Premonitory Urge for Tics Scale; SES = socioeconomic status; SRS = Social
Responsiveness Scale.

Predictor

Group 1 (N)

mean ± SD

Group 2 (N)

mean ± SD

F

p

Sex

M (26)

14.192 ± 5.685

F (13)

14.077 ± 8.470

0.003

0.956

First-degree relative with tics

Yes (15)

11.933 ± 5.216

No (24)

15.542 ± 7.126

3.445

0.072

- Parent with tics

Yes (9)

12.333 ± 5.220

No (30)

14.700 ± 6.979

1.057

0.311

Phonic tics (ever)

Yes (32)

14.844 ± 6.441

No (7)

11.000 ± 7.047

2.313

0.137

3 or more vocal tics

Yes (11)

18.364 ± 5.853

No (28)

12.500 ± 6.251

8.160

0.007

Tic below the neck

Yes (27)

14.519 ± 6.963

No (12)

13.333 ± 6.005

0.318

0.576

Non-tic K-SADS diagnosis

Yes (31)

14.516 ± 6.708

No (8)

12.750 ± 6.541

0.542

0.466

ADHD diagnosis

Yes (14)

12.786 ± 7.319

No (25)

14.920 ± 6.231

1.159

0.289

OCD diagnosis

Yes (5)

15.600 ± 7.403

No (34)

13.941 ± 6.601

0.334

0.567

Anxiety disorder

Yes (20)

16.000 ± 6.882

No (19)

12.211 ± 5.912

4.250

0.047

Table 4. Mean YGTSS total tic score (TTS) at 12 months stratified by categorical variables measured at baseline.
F statistic and p value reported for ANCOVA.
Awareness, Social Cognition, Social Communication, Social Motivation, and Autistic Mannerisms). Significant
relationships were found between 12-month TTS and Social Communication, Social Motivation, and Autistic
Mannerisms Subscales (See Table 3). The CBCL’s Anxious/Depressed, Attention Problems, and Aggressive
Behavior syndrome scale T scores were summed to yield a CBCL A-A-A score that is often used to define deficient emotional self-regulation (DESR). Partial correlation analysis revealed a relationship between the CBCL
A-A-A scores and 12-month TTS, controlling for baseline TTS, rpartial = 0.406, p = 0.011 (Spearman). The estimated Bayes factor BF10 was 2.47, indicating weak evidence in favor of adding CBCL A-A-A total score to the
null model with baseline TTS alone. Further analysis with each of the subscales revealed a significant relationship
with the Anxious/Depressed, but not the Attention Problems or Aggressive Behavior subscores (See Table 3). The
CBCL/6-18 was used for all participants. For the scoring of our 5-year-old participants, age was entered as 6 years.
The analysis was conducted again without the 5-year-old participants, and CBCL A-A-A scores still significantly
predicted the 12-month tic outcome, n = 31, rpartial = 0.452, p = 0.012 (Spearman). Other potential continuous
predictors, including age at tic onset, the interval between the baseline visit and 12-month follow-up visit, IQ,
SES, ADHD Rating Scale, and CY-BOCS, did not significantly predict 12-month TTS controlling for baseline
TTS (See Table 3).
For categorical variables, ANCOVA revealed a significant main effect of anxiety disorder (diagnosis of any
anxiety disorder at baseline) F(1,37) = 4.25, p = 0.047, as the participants with an anxiety disorder showed more
severe 12-month TTS (M = 16.000, SD = 6.882) than the participants who did not have an anxiety disorder
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Figure 1. Predictors of tic severity outcome. Plots display the correlations between the residuals of 12-month
YGTSS total tic score (TTS) and the residuals of DCI (a), SRS total T (b), and CBCL A-A-A (c) after regression
of baseline TTS. (d) Mean TTS at baseline (circle) and at 12-month (triangle) for each categorical predictor.
(M = 12.211, SD = 5.912). The estimated Bayes factor BF10 was 1.51, indicating weak evidence in favor of the
model with the presence of anxiety disorder and baseline TTS over the null model with baseline TTS alone. There
was a trend toward a significant difference based on family history, such that participants with a first-degree relative(s) with a history of tics (either parents or sibling) showed less severe tic symptoms (M = 11.933, SD = 5.216)
than participants without an affected first-degree relative (M = 15.542, SD = 7.126), F(1,37) = 3.445, p = 0.072.
As this trend was opposite to the expected direction, the baseline visit TTS was compared between subgroups
to test for a possible sample bias. Participants with a first-degree relative with a history of tics had a lower TTS at
baseline (n = 15, mean = 16.000, SD = 5.644) than did other participants (n = 24, mean = 17.958, SD = 6.410),
but this difference was not statistically significant (independent sample t-test, t(37) = −0.970, p = 0.338). Also,
participants with 3 or more phonic tics showed less improvement at follow-up than those with 0–2 phonic tics,
F(1,37) = 8.16, p = 0.007. Other potential categorical predictors including sex, phonic tics (ever), and comorbid
diagnosis (i.e., any non-tic diagnosis on the K-SADS, or ADHD or OCD separately) did not reveal a statistically
significant difference (Table 4).
To minimize the effect of multiple comparisons, a stepwise multiple regression analysis was conducted to
predict 12-month TTS with all the predictors identified above: baseline TTS, SRS total T score, DCI score, CBCL
A-A-A score, and the presence of anxiety disorder. The participant whose DCI value was an outlier (≥3 SD) was
excluded from the analysis, so stepwise multiple regression was conducted on the remaining 38 participants. The
final model of SRS total T score, baseline TTS, and the presence of anxiety disorder explained nearly half the variance in 12-month TTS (R2 = 0.447, F(3,34) = 9.176, p < 0.001; adjusted R2 = 0.399). DCI total score and CBCL
A-A-A score were excluded from the final model (p > 0.05). See Table 5 for full details on the model at each step.

Discussion

Outcome. In this, the largest prospective study on the outcome of recent-onset tic disorder, we demonstrated

that tics do not remit within a year in most children with recent-onset tics. These results are surprising, given the
received wisdom among clinicians that PTD usually is temporary and disappears within a few months2,10,13–21,
before Tourette syndrome can be diagnosed. In the current study, most children were no longer bothered by
their tics one year after tic onset, and several had no tics visible during a long clinical visit that included extensive
tic history from parent and child and a neurological exam. However, all children had tics within the past week,
sometimes only observed by camera while sitting alone in a separate room. The diagnostic outcome depends in
large measure on how remission is defined, as the changes in diagnostic criteria from DSM-IV to DSM-IV-TR to
DSM-5 substantially impact the remission rates in these children. According to DSM-IV, which required marked
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12-month TTS
Model 1
Variable

B

Constant

−5.546

SRS total T score

0.393*

baseline TTS

Model 2
β

B

Model 3
β

−11.242
0.486

B

0.363*

0.449

0.35*

0.433

0.427*

0.378

0.444*

0.393

3.435*

0.264

Anxiety disorder
R2

0.237

0.378

0.447

F

11.155*

10.635*

9.176*

ΔR2
adjusted R2

0.215

β

−12.629

0.141

0.069

0.342

0.399

Table 5. Hierarchical multiple regression predicting 12-month TTS from SRS total T score, baseline TTS,
and the presence of anxiety disorder. N = 38; *p < 0.05; B indicates unstandardized coefficients; β indicates
standardized coefficients.

distress or impairment in a life role to diagnose a tic disorder, only 6 of 39 participants met criteria for Tourette’s
Disorder at follow-up. However, according to DSM-5, even if all 4 of the participants lost to follow-up remitted
completely, at least 90% of the total sample met criteria for Tourette’s Disorder or Persistent (Chronic) Motor Tic
Disorder at follow-up (95% CI = 78.4% to 96.3%). Regardless of the diagnostic criteria, we show that tics do not
remit in most children within a year, if one includes careful history and adequate direct observation.
Many experts have opined that Provisional Tic Disorder (PTD) usually goes away within a period of
months2,10,13–21. We note several factors that may explain the apparent disparity. First, in our series, most parents
no longer felt the need for clinical attention by the one-year anniversary of their child’s first tic. Therefore, failure
to return to the clinic may be misinterpreted as remission of tics. Second, some of the children who had tics when
sitting alone showed no evidence of tics during a clinical interview and examination much longer than a typical
follow-up visit in a busy clinical practice. Tics tend to be more severe in specific situations, and being alone is one
such situation25. Thus, the absence of observed tics during a follow-up visit may be misinterpreted as remission
of tics. Third, at follow-up, most of the children had no to minimal impairment or distress, and tics without
substantial clinical import may not be diagnosed as an illness in routine clinical practice. Fourth, some previous
comments on the topic have been muddied by confusion about the definition of transient tic disorder, with many
authors confining that term only to those whose tics have already disappeared (discussed in Appendix 1 of Black
et al.7). Naturally prognosis will be better if one focuses only on those whose symptoms have already disappeared
at baseline. Finally, the one-year criterion for tic duration required to diagnose a chronic tic disorder is arbitrary,
and plausibly full tic remission does occur more commonly, but takes 1.5, 2 or 10 years.
Turning from opinion to data, only 3 previous studies to our knowledge provide direct follow-up in more than
a handful of children with PTD, and importantly, our results are broadly consistent with those studies. Bruun and
Budman12 reported on 58 children with PTD, but much of the follow-up was by phone call, 2–14 years after initial
intake. Only 17% of their sample remained remitted over time. Spencer and colleagues retrospectively conducted
a structured clinical interview in 36 adults with ADHD who had met criteria for TS or another tic disorder (onset
before age 21); tics had remitted in 53% of them after follow-up 1–55 years later11. Finally, Shapiro and colleagues
followed up by telephone with 26 patients 1–11 years after an initial diagnosis of PTD, and only 35% reported
full remission10. Overall, the estimate from these prospective studies was that about one third of patients with
PTD remitted fully at follow-up periods of a year or more (Appendix 1 of Black et al.7). Our results suggest that
this fraction is even smaller. We highlight that the previous reports had less intensive examination (or none) at
follow-up and reported follow-up at substantially longer durations after tic onset than in our study.
The present results also cohere with what is known about tic remission throughout the course of tic disorders
over the lifespan. Chronic tic disorders have been reported to remit by late adolescence and early adulthood in
roughly one third of patients over 5–10 years of follow-up26. However, other studies have shown that tics are still
present in 85–90% of TS patients at follow-up, including in subjects who believe their tics have disappeared27–29.
Furthermore, tics almost always wax and wane in severity while present. As noted by Bruun and Budman12, tics
often appear with “intervening spontaneous remissions”, and in their experience “complete, life-long remissions
are rare”; rather, “the more common course is one of occasional recurrences of mild tics throughout adult life”.
Similarly, Shapiro et al.10 (p.188) reported spontaneous remissions, lasting <1 month to 19 years, in 27.1% of
patients with TS, and a recent report highlighted the possible recurrence of tics after decades-long apparent
remissions30. Thus, full remission is not the typical outcome even when chronic tic disorders appear to remit.
Nevertheless, prior to the present report, full remission was expected for most children with PTD.

Predictors of prognosis. Previous studies suggested variables that might predict future tic outcome, including sex, age, tic phenomenology, tic duration, and comorbidity7, and we tested those in this sample. Some significant predictors were features of the tics themselves at baseline. Baseline tic severity (TTS) was significantly
correlated with 12-month tic severity (TTS), so we included the baseline TTS in all additional prognostic analyses. Combining DCI score, which measures typical features of TS, with TTS better predicted outcome than
did TTS alone, perhaps because DCI reflects the cumulative variety of symptoms whereas YGTSS TTS reflects
current severity. Additionally, consistent with the prior report of Shapiro et al.10 (p.374), three or more phonic tics
at baseline predicted worse tic outcome at the follow-up visit.
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Interestingly, non-tic symptoms also predicted tic outcome. Higher SRS scores (autism traits), higher CBCL
A-A-A scores (deficient emotional self-regulation), and presence of an anxiety disorder at baseline were each
associated with worse tic outcome at 12-month follow-up. Together with tics, these may indicate problems with
brain systems that are not perfectly tied to our current nosology. For instance, Althoff and colleagues31 discussed
the A-A-A profile (CBCL-DP) as sensitive to dysregulation in multiple domains, including affect (anxiety/mood),
behavior (disruptive), and cognition (attention). They viewed this profile as a global deficit in self-regulation
related to processes of effortful control as defined by Eisenberg and Spinard32. Mildly elevated SRS scores may
similarly indicate dysregulation of communication, social behavior, and motor function. In this view, tics may be
another indicator of behavioral dysregulation, with dysregulation in multiple domains indicating greater overall
severity, which may predict persistence of tics (and perhaps of other symptoms). More anxious children may
also show more tics because tics are exacerbated by moment-to-moment changes in stress or anxiety33,34. In the
Supplement we discuss alternative potential explanations for the association of these non-tic symptoms at baseline with tic outcome.

Limitations. The present sample by necessity was not epidemiologically representative; for instance, any
study like ours will over-represent parents who notice tics and are able to participate. The typical delay from
onset of tics to diagnosis (estimated retrospectively) has been reported as 10 years35, highlighting the difficulty in
studying the PTD population from clinical samples alone. Understanding that problem, in order to meet the goal
of enrolling participants within the first few months after tic onset, we recruited vigorously rather than passively
waiting for patients to come to clinical attention. Specifically, we placed advertisements around the community, talked to and left flyers with local physicians, gave information to local elementary schools, and so forth.
Therefore, the majority of our sample did not come from the clinic (see Table S1). More concerning is whether the
sample was biased to enroll children with features linked to higher or lower remission rate. One example would
be positive family history, as discussed above. Another example would be more severely affected children, who
may come more quickly to clinical attention. However, the severity at presentation in our sample was not especially high, with TTS generally low at enrollment (mean 17.23 ± 6.15). Additionally, four of the children came
from families of pediatric neurologists or child psychiatrists, and nine children had a parent or sibling with tics;
both groups would be expected to be sensitive to mild tics. Thus, overall, we contend that the sample is reasonably
representative of the population.
Future directions. We have collected additional data in this sample in other domains, including a standardized tic suppression task36,37, a measure of habit learning38, the Purdue Pegboard task39, structural MRI with automated basal ganglia volumetry40,41, and resting state functional connectivity MRI42. Those data will be subjects for
later reports. Considering the multiple-domains dysregulation hypothesis discussed above, other forms of motor
dysregulation may also be relevant (such as poor motor coordination and other subtle neurological signs), so we
are assessing more recently enrolled participants with the PANESS43,44.
Conclusions. This study provides for the first time face-to-face assessment and prospective follow-up on a
reasonably large sample of children with PTD as soon as practicable after tic onset. Although most children’s tics
improve substantially by the first anniversary of their first tic, careful and thorough assessment shows that tics are
still present. In addition to greater tic severity and variety at baseline, the presence of an anxiety disorder, high
scores on the CBCL A-A-A measure, and higher (though still subsyndromal) SRS scores can provide clinically
useful information for predicting higher likelihood that tics will be more severe at follow-up.

Methods
Subjects.

Participants included were children with current tics whose tics began within the 6 months prior
to the baseline study visit. Exclusion criteria included neurological disorder other than tics or migraine, known
structural brain disease, mental retardation, DSM-IV-TR autistic disorder, psychosis, mania, current major
depression, severe systemic illness, and non-proficiency with the English language. Recruitment sources included
clinical referrals (mostly from the Washington University School of Medicine Movement Disorders Center clinic,
with some from community doctors or the child neurology and child psychiatry departments) and various advertising methods. Of 105 potential participants contacted, we enrolled 43 (Table 1 for sample characteristics, and
Supplementary Table S1 for enrollment by recruitment source).
To determine the best estimate of the date of tic onset, we gathered multiple sources of information, including
in-depth discussion about tic onset with the child and parent/guardian at the beginning of the study visit, queries
during diagnostic interviews with the child and parent/guardian, and in some cases, reviewing home videos or
contacting current and past teachers of the child, as described previously36. Repetitive behaviors that were diagnostically ambiguous (e.g., knuckle popping, skin picking) were not considered for dating tic onset. Since the
historical information was imperfect, children were not excluded if they had a possible single past tic that had
lasted less than 3 months and had disappeared at least one year prior to the current episode. This was the case for
three participants (ages 8.5, 12.3 and 14.3 years). Assuming the previous phenomenon was indeed a tic, then these
3 met criteria at baseline for a recurrent episode of Transient Tic Disorder under DSM-IV-TR, but for Tourette’s
Disorder under DSM-5. The remaining 40 participants met criteria at screening for both DSM-IV-TR Transient
Tic Disorder and DSM-5 PTD (see Table 2).

Protocol. Children participated in a baseline study visit within 6 months of tic onset. This study visit occurred

over two days. The first day consisted of in-depth clinical interviews and assessments, behavioral tasks (including
a tic suppression paradigm in which the child was video recorded while sitting alone)36,37, and a mock MRI scan.
The second day consisted of an MRI scan and, if needed, completion of behavioral tasks. MRI and behavioral
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task data will be reported separately. Children also participated in a longitudinal follow-up visit on the 12-month
anniversary of tic onset, i.e., 6–12 months after the baseline study visit. This timing was chosen because accepted
diagnostic criteria for a chronic tic disorder require tics to have been present for at least one year. This follow-up
visit included clinical assessments in order to assess tic disorder diagnosis and changes in symptoms and comorbidities since the baseline study visit.

Clinical assessments.

At the baseline study visit, psychiatric diagnoses were evaluated using the Kiddie
Schedule for Affective Disorders and Schizophrenia (K-SADS)45; parents and children were interviewed separately by two of three trained raters who all had masters-level credentials in counseling or social work, at least 3
years’ experience with psychiatric diagnostic interviewing, and additional training with author KJB on psychiatric diagnosis in TS. Symptom severity measures for the past week, including the Yale Global Tic Severity Scale
[YGTSS; total tic score range 0–50, impairment score range 0–5046], Children’s Yale-Brown Obsessive Compulsive
Scale [CY-BOCS; range 0–4047], and ADHD Rating Scale [range 0–5448], were scored by author KJB after interview, neurological examination, and review of K-SADS data and parent questionnaires. On each of these scales,
higher scores indicate greater severity. Typical historical features of TS were assessed by author KJB with the
Diagnostic Confidence Index [DCI; range 0–100, higher scores indicate more features of classic TS33]. To assess
premonitory symptoms, the Premonitory Urge for Tics Scale [PUTS; range 9–36, higher scores indicate more premonitory symptoms24] was administered by author KJB to the child with parental help if needed. Author KJB also
provided a DSM-5 diagnosis for all children for tic disorders, Attention-Deficit/Hyperactivity Disorder (ADHD),
and Obsessive-Compulsive Disorder (OCD) after reviewing all information49. The K-BIT II was administered
by a trained rater to the child to estimate IQ50. Parents completed the following: YGTSS tic symptom checklist,
Child Behavior Checklist [CBCL51], Social Responsiveness Scale [SRS52], Barratt Simplified Measure of Social
Status [SES53], Pediatric Quality of Life Inventory [PedsQL54], and forms to record handedness, history of maternal smoking or other problems during pregnancy, history of birth complications, and pertinent family history.
Midway through the study, we added a question to the protocol asking if the parent/guardian would be taking
their child to the doctor now or in the near future because of his/her tics.
The follow-up visit included the following: YGTSS, CY-BOCS, ADHD Rating Scale, DCI, PUTS, CBCL,
PedsQoL, and clinical examination by author KJB for tic disorder, ADHD, and OCD diagnosis. Study data were
managed using REDCap [Research Electronic Data Capture] electronic data capture tools hosted at Washington
University55.

Statistical analysis.

A major goal of this work was to identify clinical features at baseline that could predict outcome at follow-up. To assess outcome, 12-month YGTSS Total Tic Score was the dependent variable
in the analyses. Our original proposal focused on change in YGTSS Total Tic Score over time (ΔTTS) as the
dependent variable as a way of simplifying power calculations (http://osf.io/y5vxj), and that analysis appears
in the Supplement. However, the ΔTTS is susceptible to a floor effect for participants with low TTS at baseline,
and the more clinically relevant outcome is symptom severity at follow up (12-month TTS) rather than degree of
improvement.
For the continuous variables, outliers (≥3 SD) were removed from the analysis. Shapiro-Wilk test revealed that
most of the variables were not normally distributed, so both Pearson and Spearman partial correlation analyses
were conducted between each of the candidate predictor variables and 12-month TTS after controlling for the
baseline TTS. In the main text, we reported the results of Pearson partial correlation when the data were normally
distributed, and the results of Spearman partial correlation if the data were not normally distributed. For the categorical variables, an ANCOVA was conducted to test if subgroups divided by the candidate predictors showed
a different degree of 12-month TTS after controlling for baseline TTS. To minimize the effect of multiple comparisons, a stepwise multiple regression analysis was conducted to predict 12-month TTS with all the predictors
that were significantly associated with the tic outcome at 12-month. In addition, to complement the limitation of
conventional null hypothesis significant testing56, we conducted Bayesian hypothesis testing using JASP57 with
BIC method. BF10 over 3 was considered as positive58/substantial59 evidence (strong evidence if BF10 > 10)60.

Ethics approval and consent to participate. The study was approved by the Washington University
Human Research Protection Office (IRB), protocol numbers 201109157 and 201707059. Each child assented and
a parent (guardian) gave informed consent prior to study participation. All participants were compensated for
their time. All experiments were performed in accordance with relevant guidelines and regulations61.

Data Availability

The supplementary data file provides individual participant data.
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